Status:
COMPLETED
CPT Testing for Sacral Neuromodulation Outcomes
Lead Sponsor:
Corewell Health East
Conditions:
Incontinence
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a prospective study. Subjects will be recruited from the urology practices of Dr. Ken Peters and Dr. Ananias Diokno at William Beaumont Hospital. Subjects will be referred to the study by the ...
Detailed Description
Patients will be scheduled 1-2 weeks prior to planned implantation of the SNM wire electrode (Stage 1). Patients that do not have a 50% improvement in their symptoms in Stage 1 will not go on to Stage...
Eligibility Criteria
Inclusion
- Established diagnosed overactive bladder
- Scheduled to receive SMN therapy by Dr. Peters or Dr. Diokno
- Women at least 18 years of age
- Capable of giving informed consent
- Capable and willing to follow all study related procedures (e.g. bladder and urethral catheterization, answering questions during CPT testing, complete questionnaires regarding pertinent medical history).
Exclusion
- Current Urinary tract infection
- Currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.
- Pregnancy or intending to become pregnant during the study
- Cannot independently comprehend and complete relevant medical history questionnaires.
- The subject is deemed unsuitable for enrollment in this study by the investigators based on their history.
- Men are excluded
- TENS, PTNS or acupuncture therapy currently being used for symptoms
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00617786
Start Date
October 1 2008
End Date
July 1 2010
Last Update
November 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073